Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B01AF01	RIBAVAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
B01AF01	RIXALTA 15	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,164,664 L.L
B01AF01	VAROXA	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	952,208 L.L
B01AF02	ELIQUIS	B	Apixaban - 5mg	5mg	Tablet, film coated	4,183,603 L.L
B01AF02	APIXEL	G	Apixaban - 5mg	5mg	Tablet, film coated	1,750,579 L.L
B01AF02	APO-APIXABAN	G	Apixaban - 5mg	5mg	Tablet	3,084,119 L.L
B01AF02	AVIXAN	G	Apixaban - 5mg	5mg	Tablet, film coated	2,777,275 L.L
B01AF02	ELAPIX 5	G	Apixaban - 5mg	5mg	Tablet, film coated	1,970,969 L.L
B01AF02	ELIQUIS	B	Apixaban - 2.5mg	2.5mg	Tablet, film coated	4,183,603 L.L
B01AF02	APIXEL	G	Apixaban - 2.5mg	2.5mg	Tablet, film coated	1,750,579 L.L
B01AF02	APO-APIXABAN	G	Apixaban - 2.5mg	2.5mg	Tablet	3,084,119 L.L
B01AF02	AVIXAN	G	Apixaban - 2.5mg	2.5mg	Tablet, film coated	2,777,275 L.L
B01AF02	ELAPIX 2.5	G	Apixaban - 2.5mg	2.5mg	Tablet, film coated	1,970,969 L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 2.5mg/0.5ml	2.5mg/0.5ml	Injectable solution	5,341,774 L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 7.5mg/0.6ml	7.5mg/0.6ml	Injectable solution	12,004,668 L.L
B02AA02	EXACYL	B	Tranexamic acid - 500mg/5ml	500mg/5ml	Injectable solution	748,520 L.L
B02BA01	PHYTOMENADIONE (VITAMINE K1) PANPHARMA	G	Phytomenadione - 10mg/ml	10mg/ml	Solution	740,457 L.L
B02BA01	KONAKION MM PEDIATRIC	B	Phytomenadione - 2mg/0.2ml	2mg/0.2ml	Solution	442,124 L.L
B02BB01	FIBRYGA	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution+solvent	40,915,563 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	41,515,083 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	53,437,592 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	24,369,850 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	13,394,024 L.L
B02BD01	OCTAPLEX	BioHuman	Prothrombin complex, human (PPSB) - 500IU	500IU	Injectable powder for solution+diluent	35,220,164 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	14,098,526 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,247,110 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	28,437,886 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	26,495,478 L.L

...

189